Bausch Health: Q2 Beat And Cheap, But Debt Overhang Remains Substantial (NYSE:BHC)
· seekingalpha.com
Bausch Health Companies Inc. stock jumped 40% after Q2 beats and higher FY2026 guidance, but $15B debt risk persists. Click for more on BHC stock.
Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a m...